NEWS
18.1.2012
JSR Expands its Biomedical Business by investing in BIA Separations' Unique Purification Technology
Tokyo, Japan, January 18, 2012 - JSR Corporation (Head Office: Minato-Ku, Tokyo, President: Mitsunobu Koshiba) and BIA Separations (Head Office: Villach, Managing Director and CEO: Aleš Štrancar) announced that they have entered a Strategic partnership which includes a minor equity position by JSR on November 14th 2011. As a result of this investment, JSR and BIA Separations have started a joint global marketing and sales effort and collaborative R&D activities in the area of downstream purification as part of the manufacturing of vaccine, DNA and antibody based medicines.
21.10.2011
Change of Addres Notification
Dear Customers: We are pleased to announce that with Oct 21st, Slovenian subsidiary BIA Separations d.o.o., has moved to its new R&D and production facility in Ajdovscina, Slovenia.

Our new address is:

BIA Separations d.o.o.
Mirce 21, 5270 Ajdovscina, Slovenia
Tel: +386 59 699 500
Fax: +386 59 699 599

11.10.2011
CIM Protein Disk Will Remain in Our Product Offering in 2012
Dear valued customers:

Due to a number of your requests to keep our line of CIM ® Protein Disks in our regular product offering in 2012, we decided to honor your wishes. The entire line of CIM® Protein Disks will continue to be available for purchase in 2012 and beyond.

EVENTS
Educational Webcast - Solutions for Production and Analysis of Vaccines, Viruses and Gene Theraphy Vectors
Watch immediately!